Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of MEDI8897 in healthy adults to support further development for Respiratory Syncyti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• MEDI8897

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED | Results posted: 2016-11-28